📉 The Financial Deep Dive
Indo National Limited's unaudited financial results for the quarter and nine months ended December 31, 2025, paint a concerning picture of deteriorating profitability, particularly on a consolidated basis.
The Numbers:
Standalone Performance: For Q3 FY26, revenue from operations stood at ₹10611.30 Lakhs, a 12.77% decrease year-on-year from ₹12163.30 Lakhs in Q3 FY25. The company reported a net loss after tax of ₹(661.95) Lakhs for the quarter, a stark reversal from a profit of ₹63.18 Lakhs in the previous year. Consequently, basic and diluted EPS fell to ₹(8.83) from ₹0.84 YoY. For the nine months ended December 31, 2025, standalone revenue was ₹34462.22 Lakhs (down 4.52% YoY), with a net loss of ₹(231.68) Lakhs compared to a profit of ₹364.41 Lakhs in 9M FY25. EPS for the nine-month period was ₹(3.09) versus ₹4.86 YoY.
Consolidated Performance: The consolidated results reveal an even more severe profit decline. Q3 FY26 revenue was ₹10630.91 Lakhs (down 12.61% YoY). The consolidated net loss after tax for the quarter was ₹(785.22) Lakhs, a significant fall from a profit of ₹109.13 Lakhs in Q3 FY25. The most alarming figure comes from the nine months ended December 31, 2025: consolidated revenue stood at ₹34534.81 Lakhs (down 6.75% YoY), but the company posted a net loss of ₹(569.29) Lakhs. This is a dramatic contrast to a substantial profit of ₹12186.42 Lakhs in the corresponding period last year. Consolidated EPS for 9M FY26 was ₹(7.25), down from ₹164.91 in 9M FY25.
The Quality:
The primary driver for the drastic fall in consolidated profitability appears to be a collapse in 'Other Income'. For the nine months ended December 31, 2025, 'Other Income' was ₹608.16 Lakhs, a precipitous drop from ₹18677.48 Lakhs in 9M FY25. This indicates that the company's profitability in the previous year was heavily reliant on non-operational gains, and its core operating performance is under significant pressure, leading to substantial losses in the current period.
The Grill:
No specific management guidance, outlook, or concall highlights were provided in the source text. Therefore, no analyst questions or management responses could be analyzed.
Risks & Outlook:
- Regulatory Overhang: Indo National faces an ongoing appeal against a ₹42.26 Crores penalty imposed by the Competition Commission of India (CCI) for alleged cartelisation. While the company has deposited 10% of the penalty, the final resolution remains a significant financial risk.
- Strategic Investments: The company has made significant strategic investments, including acquiring a 46.76% stake in Medcuore Medical Solutions Private Limited (making it a subsidiary) and investing in Compulsory Convertible Preference Shares (CCPS) of Axial Aero Private Limited. These moves suggest a diversification strategy, but they coincide with a period of operational downturn and may require further capital outlay.
- Amalgamation and Reporting Changes: The application for amalgamation of its subsidiary, Helios Strategic Systems Limited, with Indo National Limited is underway. The integration of Helios has necessitated changes in segment reporting, with 'Consumer Goods' now being the primary segment alongside 'Composites & Aero space' and others.
- Labour Code Impact: A past period employee benefit liability of ₹86.00 Lakhs (standalone) and ₹87.00 Lakhs (consolidated) has been recognized due to the implementation of new Labour Codes, adding a minor expense.
The absence of forward-looking management guidance leaves investors uncertain about the company's strategy to arrest the decline in profitability and leverage its new investments effectively.